|Titre :||What are midwives' views of screening Prenatal women who use cannabis in pregnancy? (2023)|
|Auteurs :||Annmarie Badchkam|
|Type de document :||Article : texte imprimé|
|Dans :||Midirs. Midwifery Digest (Vol. 33, n° 2, juin 2023)|
|Article en page(s) :||p. 154-159|
Paramédical (MeSH)Appréciation des risques ; Cannabidiol ; Cannabis ; Connaissances, attitudes et pratiques en santé ; Diagnostic ; Grossesse
Background: Cannabis use within pregnancy is increasingly becoming a common habit; midwives provide vital routine prenatal screening to help encourage stop-smoking but little is known about midwives' views, beliefs and perceptions towards screening for prenatal cannabis use. The researcher has conducted an empirical study to explore and identify barriers to screening.
Method: Semi-structured interviews were conducted with seven midwives, who were asked about their views, which included describing their experiences with screening prenatal clients for cannabis use. The interview guide was developed using the modified Health Belief Model (HBM) (Roden 2004) to understand and reflect a health promotion perspective. The interviews were audio-recorded, transcribed, thematically coded and revised to identify themes.
Results: Five themes were identified from the seven interviewees' data collection. The participants perceived clients did not view cannabis as a drug and/or perceived it was less harmful than other illicit drugs. Participants reported barriers of having limited knowledge on the risks/effects associated with prenatal cannabis use, as well as lack of knowledge of medicinal cannabis, such as CBD, and how best to address cannabis use in pregnancy, which includes carbon monoxide (CO) monitoring. At times, this affected some participants' self-efficacy and their behaviour in discussing the risks associated with cannabis/CBD. Midwives also felt clients had a fear of disclosing their cannabis use.
Conclusion: This study highlighted the need for further training on the risks associated with prenatal cannabis use to aid midwives' self-efficacy in screening. Developing strategies for addressing medicinal CBD, including CO monitoring, was recommended and highlighted the current gaps in research that is needed to help eliminate barriers to screening. Hence, the findings demonstrate that midwives should consider using the HBM framework to assist with supporting prenatal women to make healthier behavioural changes.
|Localisation||Section||Support||Cote de rangement||Statut||Disponibilité|
|Bibliothèque Paramédicale||Périodiques||Périodique||MID.DIG. 23-2||Empruntable||Disponible|